The correct answer is
6 hours after reconstitution.
BCG is a
live, attenuated bacterial vaccine supplied as a lyophilized powder that must be reconstituted with its specific diluent immediately before use. Once reconstituted, the vaccine becomes fragile because it contains
no preservative to inhibit microbial growth or stabilize the live bacilli. This is the central reason for the strict discard time.
Reconstituted BCG must be discarded 6 hours after reconstitution or at the end of the immunization session, whichever comes first. The 6-hour limit is not arbitrary: beyond this window, the viability of the live
Mycobacterium bovis bacilli declines, and the risk of bacterial contamination increases because the diluent provides a medium for growth. The vaccine must also be kept
cold (2–8°C) and
protected from light during the entire 6-hour use period, since both heat and ultraviolet light accelerate loss of potency in live vaccines.
The same 6-hour discard rule applies to
measles-containing vaccines (measles, MR, MMR), which are also live, attenuated, and preservative-free after reconstitution. This shared rule is a high-yield comparison point for licensure examinations.
Watch out! Do not confuse the 6-hour rule for BCG and measles-containing vaccines with the longer discard times for other reconstituted vaccines. For example, some inactivated or subunit vaccines may be used for up to 6 hours or longer depending on the manufacturer, but the NIP standard for BCG and measles-containing vaccines is specifically 6 hours or end of session, whichever comes first.
Key point! The phrase "whichever comes first" means that if the session ends only 2 hours after reconstitution, the vial is discarded at that time, not held until the full 6 hours have elapsed. This prevents using a partially used vial at a later session when cold chain integrity and sterility can no longer be guaranteed.
| Vaccine type | Preservative after reconstitution | Discard time after reconstitution | Storage during use |
|---|
| BCG (live, attenuated) | None | 6 hours or end of session, whichever comes first | 2–8°C, protected from light |
| Measles-containing (live, attenuated) | None | 6 hours or end of session, whichever comes first | 2–8°C, protected from light |
| Other reconstituted vaccines (e.g., some inactivated) | Varies by product | Follow manufacturer or NIP guidance | Per product instructions |
The practical consequence of this rule is significant for outreach immunization sessions. Because a 20-dose BCG vial cannot be stored once opened, health workers often wait until enough infants are present before reconstituting a vial to avoid wastage. This practice, while economically rational, can delay timely vaccination if the threshold number of infants is not reached
[1]. The 6-hour window therefore represents a balance between maintaining vaccine potency and minimizing unnecessary wastage in field settings.
Cold chain management studies reinforce that health workers must understand these time limits as part of overall vaccine quality control. Knowledge of correct reconstitution, storage temperature, and discard times directly affects whether the vaccine delivered to a child is still potent and safe . A vaccine that has been reconstituted beyond 6 hours may look unchanged, but its immunogenicity is no longer reliable, and it must not be administered.
The 1-hour, 4-hour, and 24-hour options are incorrect because they do not match the NIP standard for preservative-free live vaccines. The 24-hour option is particularly dangerous because it would allow significant bacterial growth and loss of live bacilli viability, potentially leading to both ineffective immunization and injection-site complications.
References (research sources)